ResultsIQ › Latest results › Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited Q3 FY26 results press release summary
NSE: GAUDIUMIVF · BSE: 544709
Results press release of 19 Mar 2026, summarised by AI from the filing.
Gaudium IVF reported Q3 FY26 revenue from operations of ₹2,450.70 lakh and net profit of ₹363.05 lakh, following its IPO and listing.
Key takeaways
- Margins Supported by operating leverage and disciplined cost management.
- Market opportunity Fertility care in India is significantly underpenetrated; company aims to lead growth.
Gaudium IVF and Women Health Limited Q1 FY27 results
As filed: Revenue ₹19.4 cr, EBITDA ₹2.4 cr, PAT ₹1.8 cr, EBITDA margin 12.5%.
Not scored. Too small to score: quarter revenue ₹19.4 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹30.4 cr, EBITDA ₹12.2 cr, PAT ₹8.4 cr, EBITDA margin 40.1%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.4 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −7.0% in 28 days (Nifty 500: +0.6%).
- Q3 FY26: Revenue ₹24.5 cr, EBITDA ₹6.6 cr, PAT ₹3.6 cr, EBITDA margin 26.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹24.5 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +2.2% in 30 days (Nifty 500: +4.3%).
Past price moves after results do not indicate future moves. Not a recommendation.
Gaudium IVF and Women Health Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.